Explore more publications!
Health Network San Marino
Got News to Share?

Health Network San Marino: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Network San Marino.

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

Press releases published on April 10, 2026

Nightfood Holdings Inc. (OTCQB: NGTF) Brings AI-Enabled Robotics Platform to Growing Pharma Manufacturing Space
Apr. 10, 2026

Nightfood Holdings Inc. (OTCQB: NGTF) Brings AI-Enabled Robotics Platform to Growing Pharma Manufacturing Space

Indeterminate GlobeNewswire
BiomX Acquires Zorronet, Autonomous AI Command-and-Control Platform for Real-Time Defense and Security Applications
Apr. 10, 2026

BiomX Acquires Zorronet, Autonomous AI Command-and-Control Platform for Real-Time Defense and Security Applications

Indeterminate GlobeNewswire
Annovis Closes $10 Million Offering, Extending Cash Runway Through Phase 3 Alzheimer's Disease 6-Month NDA Submission
Apr. 10, 2026

Annovis Closes $10 Million Offering, Extending Cash Runway Through Phase 3 Alzheimer's Disease 6-Month NDA Submission

Indeterminate GlobeNewswire
FibroBiologics Presents Novel Thymus Organoid Platform to Combat Age-Related Immune Decline at Keystone Symposia on Aging and Immunity
Apr. 10, 2026

FibroBiologics Presents Novel Thymus Organoid Platform to Combat Age-Related Immune Decline at Keystone Symposia on Aging and Immunity

Indeterminate GlobeNewswire
Global Bispecific Antibodies Market to Reach $22.3 Billion by 2030 as Immuno-Oncology Innovation and R&D Investment Accelerate
Apr. 10, 2026

Global Bispecific Antibodies Market to Reach $22.3 Billion by 2030 as Immuno-Oncology Innovation and R&D Investment Accelerate

Indeterminate GlobeNewswire
LifeMD® Now Offering Eli Lilly and Company’s Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management
Apr. 10, 2026

LifeMD® Now Offering Eli Lilly and Company’s Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management

Indeterminate GlobeNewswire
Enovis to Host First Quarter 2026 Results Conference Call on May 7th
Apr. 10, 2026

Enovis to Host First Quarter 2026 Results Conference Call on May 7th

Indeterminate GlobeNewswire
Milestone Pharmaceuticals Announces RESET-PSVT Registry to Generate Real-World Evidence on CARDAMYST™ (etripamil) Nasal Spray in Patients With PSVT
Apr. 10, 2026

Milestone Pharmaceuticals Announces RESET-PSVT Registry to Generate Real-World Evidence on CARDAMYST™ (etripamil) Nasal Spray in Patients With PSVT

Indeterminate GlobeNewswire
Unyte Health Acquires Vital Links and Vital Sounds, Developers of Therapeutic Listening®
Apr. 10, 2026

Unyte Health Acquires Vital Links and Vital Sounds, Developers of Therapeutic Listening®

Indeterminate GlobeNewswire
NeurAxis, Inc. Announces Preferred Stock Dividend
Apr. 10, 2026

NeurAxis, Inc. Announces Preferred Stock Dividend

Indeterminate GlobeNewswire
Opus Genetics Announces Data Presentations at the 2026 American Society of Cataract and Refractive Surgery Annual Meeting
Apr. 10, 2026

Opus Genetics Announces Data Presentations at the 2026 American Society of Cataract and Refractive Surgery Annual Meeting

Indeterminate GlobeNewswire
Zhen-Ao Group Showcases Core 5'-Nucleotide Breakthroughs in Cambridge, Illuminating a Chinese Path for Global Technology-Driven Anti-Aging
Apr. 10, 2026

Zhen-Ao Group Showcases Core 5'-Nucleotide Breakthroughs in Cambridge, Illuminating a Chinese Path for Global Technology-Driven Anti-Aging

Indeterminate GlobeNewswire
TRICARE Now Covers Online Therapy in New York — $0 Copay for Active-Duty Families Through MMHC
Apr. 10, 2026

TRICARE Now Covers Online Therapy in New York — $0 Copay for Active-Duty Families Through MMHC

Indeterminate GlobeNewswire
Best ACV Gummies Claims Evaluated: What Ingredient Labels Actually Disclose vs. What Marketing Pages Emphasize — 2026 Consumer Transparency Update
Apr. 10, 2026

Best ACV Gummies Claims Evaluated: What Ingredient Labels Actually Disclose vs. What Marketing Pages Emphasize — 2026 Consumer Transparency Update

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions